Latest News Companion animals

01 February 2022

IDEXX and One Health bring dog DNA test to labs

Precision medicine firm, One Health Company, will collaborate with IDEXX Laboratories, Inc. to increase the reach of its FidoCure Next Generation DNA Sequencing Test. The collaboration is intended to spread access to the cancer test platform to Canadian and American pet patients.

“We are tremendously excited to collaborate with a global leader in veterinary diagnostics to help bring our novel FidoCure Next Generation DNA Sequencing Test to even more veterinary clinics across the U.S. and Canada,” said Christina Lopes, co-founder, and chief executive officer of One Health Company. “IDEXX's customer- and innovation-centric approach to veterinary diagnostics is an ideal complement to FidoCure's precision medicine platform.”

The new test adds to the portfolio in cancer management from IDEXX Labs. Some 2,000 canines have utilized the FidoCure test and received targeted treatment based on results, according to the company. Results of the cancer test are also used to increase understanding of canine cancers as a whole.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

IDEXX and One Health bring dog DNA test to labs

Comments

List

Add

Tag

Related Articles

29 August 2025
IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories Announces Second Quarter Results

23 July 2025
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

13 November 2024
ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

27 December 2023
IDEXX Laboratories Schedules Two Institutional Investor Events

IDEXX Laboratories Schedules Two Institutional Investor Events

22 May 2023
AVMA News: Map shows heartworm rates continue to increase

AVMA News: Map shows heartworm rates continue to increase

More news

Advancing the 3Rs: innovation, implementation, ethics and society

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

One Committed and Caring NC State Veterinary Student, So Many Choices

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Newsletter

News of interest

Philanthropic Support and Specialized Surgery Saves Dog with Oral Tumor

Feline asthma syndrome: A retrospective study of the clinical presentation in 29 cats

Feline neurological diseases in a veterinary neurology referral hospital population in Japan

Treatment of cats with feline infectious peritonitis

EVENTS